共 138 条
[1]
Leon DA(2006)Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data Lancet 367 52-56
[2]
McCambridge J(2005)Dose adjustment in patients with liver disease Drug Saf 28 529-545
[3]
Delco F(2004)Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes Dig Dis Sci 49 621-626
[4]
Tchambaz L(1979)Hepatic first-pass metabolism in liver disease Clin Pharmacokinet 4 423-432
[5]
Schlienger R(2002)Assessment of portal hemodynamics by ultrasound color Doppler and laser Doppler velocimetry in liver cirrhosis Indian J Gastroenterol 21 176-178
[6]
Drewe J(1998)Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6 Clin Pharmacol Ther 64 8-17
[7]
Krahenbuhl S(1995)Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease Hepatology 21 120-128
[8]
Zuckerman MJ(1999)Pharmacokinetics of opioids in liver disease Clin Pharmacokinet 37 17-40
[9]
Menzies IS(1986)Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis Gut 27 190-195
[10]
Ho H(1992)Pharmacotherapy of ascites associated with cirrhosis Drugs 43 316-332